Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20260427069178N1Phase 3Completed
Phase 3, randomised, single-blind trial of dexmedetomidine and bupivacaine in postoperative pain (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Post-Cesarean Recovery Quality. Started May 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20260427069178N1.